|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1984-5-16
|
|
pubmed:abstractText |
The metabolism of apolipoproteins B-48 and B-100 (apo B-48 and B-100) in large triglyceride-rich lipoproteins (300 to 1500 A in diameter) has been compared in three normal subjects and two subjects with genetically determined deficiency of lipoprotein lipase. The triglyceride-rich lipoproteins were obtained from a lipoprotein lipase-deficient donor 4 hr after a fat-rich meal in order to obtain chylomicrons (containing apo B-48) and very low density lipoproteins (VLDL) (containing apo B-100), whose properties had not been modified by the action of this enzyme. The triglyceride-rich lipoproteins were labeled with 125I and injected intravenously into recipients who had fasted overnight. In normal recipients, most of the apo B-48 was removed from the blood within 15 min, and most of the apo B-100 was removed within 30 min. In the lipoprotein lipase-deficient recipients, most of the injected apo B-100 remained in the blood for more than 8 hr; removal of apo B-48 was only slightly more rapid. In all subjects, only trace amounts of either protein were found in lipoproteins more dense than 1.006 g/ml. The results indicate that (i) the removal of the apo B of both chylomicrons and large VLDL from the blood is dependent upon the hydrolysis of their component triglycerides by lipoprotein lipase, and (ii) little or no apo B-48 of chylomicrons or apo B-100 of large VLDL is converted appreciably to low density lipoproteins (LDL). Our results suggest that the reported variability of the conversion of VLDL to LDL may be related to the size and composition of the particles secreted from the liver. The rapid production of remnant particles that are removed efficiently by the liver may minimize the opportunity for further reactions leading to the formation of LDL.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/6584917-13252080,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6584917-13712364,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6584917-16745836,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6584917-172371,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6584917-172530,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6584917-177294,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6584917-192983,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6584917-198504,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6584917-209115,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6584917-211874,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6584917-240514,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6584917-414755,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6584917-4345055,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6584917-5956919,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6584917-6342527,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6584917-6644179,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6584917-6788567,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6584917-6849951,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6584917-6930644,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6584917-6930926,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6584917-6948299,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6584917-6957885,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6584917-6960858,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6584917-7076679,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6584917-7093299,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6584917-7240415
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0027-8424
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
81
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1839-43
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
|
|
pubmed:year |
1984
|
|
pubmed:articleTitle |
Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in normal and lipoprotein lipase-deficient humans.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
